Clinical Trial Update: Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for aripiprazole IM depot in acute treatment of adults with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Aripiprazole IM Depot (aripiprazole)

Snippet

Sponsor: Otsuka Beijing Research Institute | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED